Prevention and treatment of neurocognitive and other neurological impairments in HIV-infected patients on virally suppressive ART is an unmet need. Critical to filling this gap is an improved ...

HIV infection is characterized by significant neurological symptomology. Early antiretroviral (ARV) agents had dramatic toxic side effects; since the advent of ARV therapy (ART), treatment has ...